For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, Representative Director, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/

Daiichi Sankyo Completes Sale of Sun Pharma Shares

Tokyo, Japan (April, 21, 2015) – Following the announcement yesterday that Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) decided to sell the entire or part of its holdings of Sun Pharmaceutical Industries Ltd. (hereafter, Sun Pharma) shares, Daiichi Sankyo today announced that the sale of Sun Pharma shares has been completed as stated below.

  

1. Change in the number of shares held after the sale

 

(1) Number of shares held before the sale (As of April 20, 2015)	214,969,058 shares
(2) Shares sold	214,969,058 shares
(3) Number of shares held after the sale	0 shares

 

2. Impact on financial results

Daiichi Sankyo will make an announcement concerning the effect of any gain or loss on the sale of Sun Pharma shares when results of operations for the fiscal year ending in March 2015 are announced.

 

The securities described herein have not been and will not be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.